Risankizumab (anti-IL-23)

Ask supplier a question | View on supplier's website

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.

Supplier	Selleck Chemicals
Product #	A2046
Sku #	A2046-1mg*5
Pricing	1mg*5, $2339.00

Feedback